Pulmatrix Inc (PULM)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.39+2.21%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PULM
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | — | — | 7.8 | 7.3 | 6.1 | 5.2 | 12.6 | 7.9 | 0.2 | 0.3 | 0.8 | 1.2 |
| Total Revenues | — | — | — | — | — | — | — | 7.9 | 0.2 | 0.3 | 0.8 | 1.2 |
| Operating Expenses & Income | ||||||||||||
| Selling, General & Admin | — | — | — | — | — | — | — | — | — | — | — | 4.5 |
| R&D Expenses | 0.0 | 0.0 | 7.2 | 15.5 | 18.2 | 15.4 | 15.6 | 12.8 | 13.0 | 10.2 | 10.2 | 7.2 |
| Operating Income | (4.1) | (5.2) | (9.8) | (14.7) | (18.9) | (20.2) | (9.9) | (20.7) | (20.4) | (17.5) | (24.9) | (23.0) |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | — | — | — | — | — | — | — | 0.2 | 0.2 | 0.6 | 0.9 | 1.0 |
| Interest & Investment Income | 0.1 | 0.1 | — | — | — | — | 0.1 | 0.3 | — | — | — | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | (0.1) | — | — | — | 0.9 |
| Other Non-Operating Income / Expenses | 0.1 | 0.0 | 0.2 | 0.6 | 0.1 | (0.0) | (9.4) | 0.1 | (0.2) | — | — | 0.0 |
| Asset Writedown | — | — | — | — | — | — | — | 7.3 | — | — | — | — |
| EBT, Incl. Unusual Items | — | — | — | — | — | — | — | — | — | (18.1) | (30.8) | — |
| Income Tax Expense | — | — | — | — | — | — | — | — | — | (3.0) | (3.0) | 0.0 |
| Net Income | ||||||||||||
| Net Income | (4.0) | (5.2) | (9.6) | (14.1) | (18.8) | (20.2) | (19.3) | (20.6) | (20.6) | (18.1) | (27.8) | (26.2) |
| Per Share | ||||||||||||
| Basic EPS | (1.10) | (1.41) | (2.62) | (3.87) | (5.46) | (8.63) | — | — | — | — | — | — |
| Diluted EPS | (1.10) | (1.41) | (2.62) | (3.87) | (5.46) | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 3.7 | 3.7 | 3.7 | 3.7 | 3,447.7 | 2.7 | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 3.7 | 3.7 | 3.7 | 3.7 | 3,447.7 | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||
| EBITDA | — | — | (9.7) | (14.6) | (18.8) | (20.0) | (9.6) | (20.5) | (20.2) | (17.2) | (24.6) | (22.8) |
| EBIT | (4.1) | (5.2) | (9.8) | (14.7) | (18.9) | (20.2) | (9.9) | (20.7) | (20.4) | (17.5) | (24.9) | (23.0) |
| Effective Tax Rate | — | — | — | — | — | — | — | — | — | 16.4% | 9.6% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.